CHN2 and malignant colon neoplasm: This analysis revealed that low CHN2 expression in unstratified colon cancer patients significantly correlated with reduced overall survival (p < 0.001), relapse-free survival (p < 0.001), and post-progression survival (p < 0.05) (Figure 2f).